FilingSEC EDGAR8-K
Neumora Therapeutics Receives Nasdaq Delisting Warning
· SEC accepted
StageWarning
Filing content
The company received a notice from Nasdaq for failing to meet the $1.00 minimum bid price requirement and has until April 26, 2027, to regain compliance.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…